Leptin-independent hyperphagia and type 2 diabetes in mice with a mutated serotonin 5-HT2C receptor gene

被引:0
|
作者
Katsunori Nonogaki
Alison M. Strack
Mary F. Dallman
Laurence H. Tecott
机构
[1] University of California at San Francisco,Department of Psychiatry and Center for Neurobiology and Psychiatry
[2] University of California at San Francisco,Department of Physiology
[3] Merck Research Laboratories,undefined
[4] Merck & Co.,undefined
来源
Nature Medicine | 1998年 / 4卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Brain serotonin and leptin signaling contribute substantially to the regulation of feeding and energy expenditure. Here we show that young adult mice with a targeted mutation of the serotonin 5-HT2C receptor gene consume more food despite normal responses to exogenous leptin administration. Chronic hyperphagia leads to a 'middle-aged'-onset obesity associated with a partial leptin resistance of late onset. In addition, older mice develop insulin resistance and impaired glucose tolerance. Mutant mice also responded more to high-fat feeding, leading to hyperglycemia without hyperlipidemia. These findings demonstrate a dissociation of serotonin and leptin signaling in the regulation of feeding and indicate that a perturbation of brain serotonin systems can predispose to type 2 diabetes.
引用
收藏
页码:1152 / 1156
页数:4
相关论文
共 50 条
  • [31] Discovery of Novel Oleamide Analogues as Brain-Penetrant Positive Allosteric Serotonin 5-HT2C Receptor and Dual 5-HT2C/5-HT2A Receptor Modulators
    Chen, Jianping
    Garcia, Erik J.
    Merritt, Christina R.
    Zamora, Joshua C.
    Bolinger, Andrew A.
    Pazdrak, Konrad
    Stafford, Susan J.
    Mifflin, Randy C.
    Wold, Eric A.
    Wild, Christopher T.
    Chen, Haiying
    Anastasio, Noelle C.
    Cunningham, Kathryn A.
    Zhou, Jia
    JOURNAL OF MEDICINAL CHEMISTRY, 2023, 66 (14) : 9992 - 10009
  • [32] An investigation of the 5-HT2C receptor gene as a migraine candidate gene
    Johnson, MP
    Lea, RA
    Curtain, RP
    MacMillan, JC
    Griffiths, LR
    AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS, 2003, 117B (01) : 86 - 89
  • [33] 5-HT2A and 5-HT2C receptor stimulation are differentially involved in the cortical dopamine release in 5-HT2A and 5-HT2C genetic mutant mice
    Huang, M.
    Li, Z.
    Prus, A. J.
    Dai, J.
    Meltzer, H. Y.
    SCHIZOPHRENIA BULLETIN, 2007, 33 (02) : 317 - 318
  • [34] Cloning and expression of a zebrafish 5-HT2C receptor gene
    Schneider, Henning
    Fritzky, Luke
    Williams, Jesse
    Heumann, Christine
    Yochum, Marissa
    Pattar, Kala
    Noppert, Grace
    Mock, Vanessa
    Hawley, Eric
    GENE, 2012, 502 (02) : 108 - 117
  • [35] Schizophrenia, chronic hospitalization and the 5-HT2C receptor gene
    Segman, RH
    Ebstein, RP
    HerescoLevy, U
    Gorfine, M
    Avnon, M
    Gur, E
    Nemanov, L
    Lerer, B
    PSYCHIATRIC GENETICS, 1997, 7 (02) : 75 - 78
  • [36] Epigenetic Regulation of Serotonin (5-HT) 5-HT2A:5-HT2C Receptor Balance in Maladaptive Impulsivity
    Anastasio, Noelle C.
    Miller, Aaron L.
    Pyles, Richard B.
    Moeller, F. Gerard
    Ramesh, Divya
    Sowers, Lawrence C.
    Cunningham, Kathryn A.
    NEUROPSYCHOPHARMACOLOGY, 2014, 39 : S330 - S330
  • [37] Association studies of 5-HT2A and 5-HT2C serotonin receptor gene polymorphisms with prophylactic lithium response in bipolar patients
    Dmitrzak-Weglarz, M
    Rybakowski, JK
    Suwalska, A
    Slopien, A
    Czerski, PM
    Leszczynska-Rodziewicz, A
    Hauser, J
    PHARMACOLOGICAL REPORTS, 2005, 57 (06) : 761 - 765
  • [38] 5-HT2C receptor and leptin polymorphisms, obesity and metabolic syndrome in schizophrenia
    Yevtushenko, Olga
    Cooper, Stephen
    O'Neill, Ryan
    Doherty, Jeniffer
    Reynolds, Gavin
    AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS, 2006, 141B (07) : 789 - 789
  • [39] 5-HT2C receptor and leptin polymorphisms, obesity and metabolic syndrome in schizophrenia
    Yevtushenko, O.
    Cooper, S. J.
    O'Neill, R. J.
    Doherty, J.
    Reynolds, G. P.
    SCHIZOPHRENIA BULLETIN, 2007, 33 (02) : 293 - 293
  • [40] Deramciclane, a putative anxiolytic drug, is a serotonin 5-HT2C receptor inverse agonist but fails to induce 5-HT2C receptor down-regulation
    E.-P. Pälvimäki
    Hannu Majasuo
    Mikko Kuoppamäki
    Pekka T. Männistö
    Erkka Syvälahti
    Jarmo Hietala
    Psychopharmacology, 1998, 136 : 99 - 104